Study guide
6.3 Physiological Changes of Ageing and Thermoregulation
EDAIC Part I European Diploma in Anaesthesiology and Intensive Care
Track your progress as you read
Finished sections get a check mark.
1 Chapter 1: The EDAIC Part I Examination
1.1 EDAIC Part I Exam Format, Scoring and Multiple True/False Strategy
2 Chapter 2: Anatomy for Anaesthesia and Intensive Care
2.1 Functional Anatomy of the Upper Airway, Larynx, and Tracheobronchial Tree 2.2 Neuraxial Anatomy: Spine, Spinal Cord, Meninges, and Spaces 2.3 Vascular Anatomy for Central and Peripheral Cannulation 2.4 Peripheral Nerve Plexuses and Autonomic Nervous System Pathways 2.5 Thoracic Anatomy: Chest Wall, Intercostal Spaces, Pleura, Mediastinum and Heart
3 Chapter 3: Respiratory and Cardiovascular Physiology
3.1 Respiratory Mechanics, Lung Volumes, and Work of Breathing 3.2 Ventilation-Perfusion Relationships, Shunt, and Gas Exchange 3.3 Control of Breathing, Hypoxia, Altitude and Hyperbaric Physiology 3.4 Cardiac Cycle, Electrophysiology, and Ventricular Function 3.5 Vascular Resistance, Microcirculation, and Systemic Hemodynamics
4 Chapter 4: Neurophysiology, Renal, Hepatic and Acid-Base Physiology
4.1 Cerebral Blood Flow, Intracranial Pressure, and CSF Dynamics 4.2 Renal Physiology, Glomerular Filtration, and Tubular Transport 4.3 Hepatic Blood Flow, Metabolism, and Clearance 4.4 Acid-Base Regulation, Buffering Systems, and Stewart Approach
5 Chapter 5: Endocrine and Haematological Physiology
5.1 Endocrine Physiology and the Neuroendocrine Stress Response 5.2 Haemostasis Physiology, Coagulation Testing and Inherited Bleeding Disorders
6 Chapter 6: Special Patient Physiology: Maternal, Paediatric and Geriatric
6.1 Maternal Physiological Adaptations to Pregnancy and Uteroplacental Flow 6.2 Neonatal and Paediatric Physiological Differences 6.3 Physiological Changes of Ageing and Thermoregulation
7 Chapter 7: General Pharmacological Principles and Inhalational Anaesthetics
7.1 Pharmacokinetic Principles, Compartmental Models, and Clearance 7.2 Pharmacodynamic Mechanisms, Receptor Theory, and Drug Interactions 7.3 Physical Properties, Uptake, and Distribution of Volatile Anaesthetics 7.4 Minimum Alveolar Concentration (MAC), Organ Effects, and Toxicity
8 Chapter 8: Intravenous Agents, Neuromuscular Blockade and Analgesics
8.1 Intravenous Induction Agents: Propofol, Etomidate, Ketamine, and Barbiturates 8.2 Neuromuscular Blocking Agents: Depolarizing and Non-Depolarizing Drugs 8.3 Neuromuscular Monitoring and Reversal: Anticholinesterases and Sugammadex 8.4 Opioid Pharmacology, Receptors, and Non-Opioid Analgesic Agents
9 Chapter 9: Cardiovascular Drugs, Autonomic Pharmacology and Local Anaesthetics
9.1 Inotropes, Vasopressors, and Inodilators in Perioperative Care 9.2 Antiarrhythmic, Antihypertensive, and Beta-Adrenergic Antagonist Drugs 9.3 Local Anaesthetic Pharmacology, Toxicity (LAST), and Lipid Emulsion Therapy
10 Chapter 10: Haematological and Internal Medicine Pharmacology
10.1 Anticoagulant, Antiplatelet and Haemostatic Drugs and Their Reversal 10.2 Internal Medicine Drugs: Endocrine, Respiratory, Psychiatric and Antiepileptic Agents and Their Anaesthetic Interactions
11 Chapter 11: Physics, Clinical Measurement and Medical Equipment
11.1 Physical Gas Laws, Fluid Dynamics, and Resistance Principles 11.2 Anaesthetic Machines, Gas Supply Pipelines, Cylinders, and Safety Mechanisms 11.3 Breathing Systems, Vaporizer Mechanics, and Scavenging Systems 11.4 Invasive and Non-Invasive Hemodynamic and Respiratory Monitoring
12 Chapter 12: Electrical Safety, Temperature, Humidity and Gas Analysis
12.1 Electricity, Electrical Safety, Diathermy, Defibrillation, Implanted Devices and Fire 12.2 Temperature Measurement, Humidity, Gas Analysis and SI Units
13 Chapter 13: Biostatistics, Clinical Trials and Evidence Appraisal
13.1 Descriptive Statistics, Distributions, and Parametric vs Non-Parametric Tests 13.2 Hypothesis Testing, Power, Type I/II Errors, and Confidence Intervals 13.3 Clinical Study Designs, Bias, and Diagnostic Test Performance (Sensitivity, Specificity, ROC)
14 Chapter 14: General Anaesthesia, Preoperative Evaluation and Airway Management
14.1 Preoperative Risk Assessment, Cardiovascular Risk Indices, and Fasting Guidelines 14.2 The Difficult Airway: Assessment, Algorithms, and Rescue Oxygenation 14.3 Intraoperative Fluid Therapy, Goal-Directed Hemodynamics, and Blood Conservation 14.4 Post-Anaesthesia Care Unit (PACU) Management, Emergence, and Postoperative Nausea/Vomiting
15 Chapter 15: Coexisting Disease and Preoperative Investigations
15.1 Interpreting Investigations: ECG, Chest Radiograph, Lung Function and Blood Tests 15.2 Coexisting Disease I: Asthma, COPD, Obstructive Sleep Apnoea, Obesity, Liver and Renal Disease 15.3 Endocrine Disease and Emergencies: Diabetes, DKA and HHS, Thyroid, Adrenal, Phaeochromocytoma and Carcinoid 15.4 Coexisting Disease II: Neuromuscular and Neurological Disease
16 Chapter 16: Subspecialty Anaesthesia: Cardiothoracic, Vascular and Neuroanaesthesia
16.1 Anaesthesia for Cardiac Surgery and Cardiopulmonary Bypass Management 16.2 Thoracic Anaesthesia, One-Lung Ventilation, and Major Vascular Surgery 16.3 Neuroanaesthesia: Craniotomy, Sitting Position, and Traumatic Brain Injury
17 Chapter 17: Obstetric, Paediatric and Ambulatory Anaesthesia
17.1 Obstetric Analgesia and Anaesthesia: Labour, Caesarean Delivery, and High-Risk Conditions 17.2 Paediatric Anaesthesia: Induction, Airway Management, and Emergencies 17.3 Ambulatory Day-Surgery Selection, Premedication, and Elderly Patient Anaesthesia
18 Chapter 18: Anaesthetic Complications and Specialty Settings
18.1 Anaesthetic Complications: Accidental Awareness, Aspiration, Positioning Injuries, Visual Loss and Dental Damage 18.2 Anaesthesia for ENT and Laser Airway Surgery, Ophthalmic Surgery, and Laparoscopic and Robotic Surgery
19 Chapter 19: Regional Anaesthesia and Acute/Chronic Pain Management
19.1 Neuraxial Techniques: Spinal, Epidural, and Caudal Anaesthesia 19.2 Upper and Lower Limb Peripheral Nerve and Fascial Plane Blocks 19.3 Multimodal Acute Postoperative Pain Management and ERAS Pathways 19.4 Chronic and Neuropathic Pain Syndromes and Interventional Management 19.5 Palliative Symptom Control, Psychological Aspects of Pain and Multidisciplinary Pain Management
20 Chapter 20: Intensive Care Medicine: Ventilation, Shock and Organ Support
20.1 Acute Respiratory Distress Syndrome (ARDS) and Mechanical Ventilation Strategies 20.2 Sepsis-3 Definitions, Septic Shock, and Hemodynamic Resuscitation 20.3 Acute Kidney Injury, Indications for Dialysis, and Continuous Renal Replacement Therapy 20.4 ICU Sedation, Delirium, Weaning, and Brain Death Determination
21 Chapter 21: Intensive Care Medicine: Admission, Nutrition, Infection and Electrolytes
21.1 ICU Admission, Severity Scoring, Nutrition and Routine Prophylaxis 21.2 Antimicrobial Therapy, Stewardship and ICU-Acquired Infections 21.3 Electrolyte Disorders: Sodium, Potassium, Calcium, Magnesium and Phosphate
22 Chapter 22: Intensive Care and Emergency Medicine: Neurocritical Care, Poisoning and Cardiorespiratory Emergencies
22.1 Neurocritical Care: Subarachnoid Haemorrhage, Stroke, Status Epilepticus and Acute Neuromuscular Failure 22.2 Acute Poisoning: Toxidromes, Decontamination and Specific Antidotes 22.3 Acute Cardiorespiratory Emergencies: Pulmonary Embolism, Acute Severe Asthma and COPD, Non-Invasive Support and Acute Heart Failure
23 Chapter 23: Resuscitation, Perioperative Emergencies and Professional Ethics
23.1 Advanced Life Support (ALS) Guidelines and Perioperative Cardiac Arrest 23.2 Perioperative Crises: Malignant Hyperthermia and Severe Anaphylaxis 23.3 Major Trauma, Hemorrhagic Shock, and Massive Transfusion Protocols 23.4 Professional Ethics, Informed Consent, Patient Safety, and Helsinki Declaration
24 Chapter 24: Newborn, Paediatric and Obstetric Emergencies
24.1 Newborn Life Support and Paediatric Life Support 24.2 Obstetric Emergencies: Maternal Collapse, Amniotic Fluid Embolism, Uterine Inversion and Resuscitative Hysterotomy
25 Chapter 25: Burns, Environmental Emergencies and Patient Transport
25.1 Burns, Inhalation Injury, Drowning, Hypothermia, Heat Illness and Decompression Illness 25.2 Prehospital Care and Intra- and Inter-Hospital Transport of the Critically Ill
6.3 Physiological Changes of Ageing and Thermoregulation
Key Takeaways Explain This Topic AI
Arterial wall stiffening and loss of elastin cause isolated systolic hypertension and widened pulse pressure, while left ventricular diastolic dysfunction makes cardiac filling heavily dependent on the atrial kick.
Closing capacity increases linearly with age, exceeding functional residual capacity in the supine position at approximately 44 years and in the upright position at 65 years, driving baseline V / Q V/Q V / Q mismatch and age-dependent decline in arterial P a O 2 P_a\text{O}_2 P a O 2 .
Minimum alveolar concentration (MAC) for volatile agents decreases by approximately 6% per decade beyond age 40 due to decreased neuronal density and central neurotransmitter synthesis.
General anaesthesia produces a characteristic three-phase hypothermia, where Phase 1 represents internal redistribution of core thermal energy to the periphery mediated by anaesthetic-induced vasodilation.
Serum creatinine is an unreliable marker of renal function in elderly patients because concurrent sarcopenia reduces creatinine generation, masking significant reductions in glomerular filtration rate ( G F R ≈ 1 mL/min/year GFR \approx 1\text{ mL/min/year} GFR ≈ 1 mL/min/year decline after age 40).
Last updated: October 2026
6.3 Physiological Changes of Ageing and Thermoregulation
Senescence represents the progressive structural and functional decline across all physiological systems, leading to reduced homeostatic reserve and impaired organ responsiveness to stress. In elderly surgical patients, physiological changes interact with anaesthetic agents to produce heightened drug sensitivity, hemodynamic instability, perioperative hypothermia, and neurocognitive complications. A comprehensive understanding of geriatric physiology and thermoregulation is central to perioperative safety.
- 1. Cardiovascular Ageing and Haemodynamics [ AGE-RELATED VASCULAR REMODELING ]
- |
- +--------------------------+--------------------------+
- | |
- [ Loss of Arterial Elastin & Collagen Crosslinking ] [ Left Ventricular Hypertrophy ]
- | |
- Decreased Arterial Compliance Impaired Diastolic Relaxation
- Elevated Pulse Wave Velocity (Early Wave Reflection) Elevated A Wave, Inverted E/A Ratio
- | |
- Isolated Systolic Hypertension & Widened Pulse Pressure 20-30% Dependence on "Atrial Kick"
- | |
- +--------------------------+--------------------------+
- |
- [ Blunted Autonomic Responses & Baroreflex ]
- Beta-1 & Beta-2 Adrenergic Desensitization
- Maximum Heart Rate Declines: HR_max ≈ 220 - Age
- Severe Unbuffered Hypotension on Induction
- Arterial Stiffening and Pulse Wave Velocity
Elastin Degradation and Collagen Deposition: Ageing is characterized by progressive fragmentation and loss of medial elastin fibers in large conduit arteries (particularly the thoracic and abdominal aorta), accompanied by increased deposition of disorganized collagen and advanced glycation end-product cross-linking.
Loss of Arterial Compliance: The aorta transforms from an elastic, distensible reservoir (Windkessel effect) into a rigid conduit. As arterial compliance ( C = Δ V / Δ P C = \Delta V / \Delta P C = Δ V /Δ P ) declines, pulse wave velocity ( P W V PWV P WV ) increases markedly from ~5 m/s in young adults to > 10 − 15 m/s > 10-15\text{ m/s} > 10 − 15 m/s in the elderly.
Reflected Pressure Waves: In youthful elastic arteries, peripheral wave reflections return to the central aorta during diastole , augmenting coronary arterial perfusion pressure. In stiff geriatric arteries, the accelerated pulse wave reflects backward prematurely during late systole . This reflected wave augments peak systolic pressure while lowering diastolic pressure, producing isolated systolic hypertension , a widened pulse pressure , and increased left ventricular afterload that promotes concentric left ventricular hypertrophy (LVH).
Diastolic Dysfunction and Atrial Dependence
Impaired Myocardial Relaxation: Active re-uptake of calcium ions into the sarcoplasmic reticulum via the SERCA2a pump slows with age, and myocardial fibrosis increases passive ventricular stiffness. This impairs early active diastolic relaxation.
Echocardiographic Inversion ( E / A < 1 E/A < 1 E / A < 1 ): On transmitral Doppler echocardiography, early passive diastolic filling (the E wave ) diminishes, whereas late ventricular filling driven by active left atrial contraction (the A wave ) increases to compensate, producing an inverted E / A E/A E / A ratio ( < 1.0 < 1.0 < 1.0 ).
The Atrial Kick: While young healthy adults derive only 10% to 15% of left ventricular end-diastolic volume from atrial systole, the elderly patient depends on this active atrial contraction ("atrial kick") for 20% to 30% (or more) of end-diastolic filling.
Haemodynamic Vulnerability: The onset of atrial fibrillation , loss of atrioventricular synchrony (e.g. junctional rhythms), or sudden tachycardia (which truncates the diastolic filling interval) leads to a precipitous drop in left ventricular preload, a sharp fall in stroke volume, profound arterial hypotension, and acute hydrostatic pulmonary congestion.
Autonomic Dysregulation and the Baroreceptor Reflex
Beta-Adrenergic Desensitization: Ageing leads to a marked, progressive down-regulation and post-receptor uncoupling of beta-1 and beta-2 adrenergic receptors . Both chronotropic and inotropic responsiveness to endogenous catecholamines and exogenous beta-agonists (e.g. isoprenaline, dobutamine) are blunted. The maximum attainable heart rate declines reliably with age:
HR max ≈ 220 − age \text{HR}_{\max} \approx 220 - \text{age} HR m a x ≈ 220 − age
Preserved Alpha-Adrenergic Tone: In contrast to beta-receptors, vascular alpha-1 adrenergic receptor responsiveness remains relatively intact . Systemic vascular resistance tends to be higher at baseline.
Blunted Baroreceptor Reflex: Sclerosis of the carotid sinus and aortic arch reduces the stretch sensitivity of baroreceptor terminals. When systemic blood pressure drops during induction of general anaesthesia or following neuraxial sympathectomy, elderly patients fail to generate compensatory reflex tachycardia or swift vasoconstriction. Profound, unbuffered arterial hypotension is common, demanding preemptive vasopressor support.
- 2. Respiratory Senescence and Gas Exchange Mechanics
- Lung and Chest Wall Mechanics
Loss of Elastic Recoil: Progressive enzymatic degradation of alveolar septal elastic fibers produces "senile emphysema" with destruction of alveolar walls and enlargement of distal airspaces. Loss of radial alveolar tethering diminishes the inward elastic recoil of the lung, causing lung compliance to increase .
Chest Wall Stiffening: Calcification of costochondral articulations, chondrosternal synostosis, and progressive senile thoracic kyphosis stiffen the thoracic cage. Consequently, chest wall compliance decreases .
Respiratory Musculature: Sarcopenia affects the diaphragm, intercostal, and accessory muscles, reducing maximum inspiratory pressure ( P I max P_{I\max} P I m a x ) and maximum expiratory pressure ( P E max P_{E\max} P E m a x ) by 30% to 50%, weakening cough efficacy and secretion clearance. [ SENILE LUNG VOLUMES ]
- Total Lung Capacity (TLC): Relatively Constant or -10%
- +--------------------------------------------------------------+
- | Vital Capacity (VC) |
- | Decreases by 20-25% by age 70 |
- | |
- |------------------------------------+ |
- | Tidal Volume | Functional |
- |------------------------------------| Residual |
- | Expiratory Reserve Volume (ERV) | Capacity (FRC) |
- | Decreases | Increases ~10% / decade |
- +------------------------------------+-------------------------|
- | Residual Volume (RV) |
- | Increases by +50-100% by age 70 |
- +--------------------------------------------------------------+
- Static and Dynamic Lung Volumes
Residual Volume (RV): Increases by 50% to 100% by age 70. Loss of elastic tethering permits smaller dependent airways to collapse earlier during expiration, trapping gas.
Functional Residual Capacity (FRC): Increases slightly (by ~10% per decade) due to the altered balance between reduced inward lung recoil and thoracic wall stiffness.
Vital Capacity (VC): Decreases by 20% to 25% by age 70 ( V C = T L C − R V VC = TLC - RV V C = T L C − R V ).
Total Lung Capacity (TLC): Remains relatively constant or declines minimally (by ~5% to 10%) due to height loss and spinal compression.
Closing Capacity and Age-Dependent V / Q V/Q V / Q Mismatch
Closing volume ( C V CV C V ) is the volume of gas remaining in the lungs above residual volume at which dependent small airways begin to collapse during expiration. Closing Capacity ( C C CC CC ) is the sum of closing volume and residual volume ( C C = C V + R V CC = CV + RV CC = C V + R V ).
Because of progressive loss of alveolar elastic tethering, closing capacity increases steadily throughout life:
At ~44 years of age , Closing Capacity exceeds FRC in the supine position .
At ~65 years of age , Closing Capacity exceeds FRC even in the upright / seated position .
Pathophysiological Consequence: When C C > F R C CC > FRC CC > FRC , dependent terminal bronchioles close during normal, resting tidal breathing. This creates micro-atelectasis, intrapulmonary right-to-left shunt, and low ventilation-perfusion ( V / Q V/Q V / Q ) units, explaining the progressive, normal decline in resting arterial oxygen tension ( P a O 2 P_a\text{O}_2 P a O 2 ) with advancing age:
P a O 2 ≈ 100 − ( age × 0.3 ) mmHg [ or P a O 2 ≈ 13.3 − ( age × 0.04 ) kPa ] P_a\text{O}_2 \approx 100 - (\text{age} \times 0.3)\text{ mmHg}\quad [\text{or } P_a\text{O}_2 \approx 13.3 - (\text{age} \times 0.04)\text{ kPa}] P a O 2 ≈ 100 − ( age × 0.3 ) mmHg [ or P a O 2 ≈ 13.3 − ( age × 0.04 ) kPa ]
For a healthy 70-year-old breathing room air, normal resting P a O 2 P_a\text{O}_2 P a O 2 is roughly 79 mmHg (10.5 kPa); for an 80-year-old, it is roughly 76 mmHg (10.1 kPa).
Blunted Ventilatory Chemosensitivity
Both the central (medullary) response to hypercapnia and the peripheral (carotid body) response to hypoxaemia decline by up to 50% in the elderly. Sedative agents, opioids, and residual volatile anaesthetics blunt these responses further, creating high susceptibility to unrecognized hypoventilation, airway obstruction, and hypercapnic respiratory arrest.
- 3. Neurobiology and Pharmacokinetics of Ageing
- Central Nervous System and Anaesthetic Requirements
Structural Changes: Cerebral brain mass decreases by 10% to 20% between ages 30 and 80, with preferential loss of gray matter in the frontal cortex, temporal cortex, and hippocampus. Neuronal density declines, alongside a marked reduction in dendritic synapses.
Neurochemical Deficits: Synthesis and receptor density of key neurotransmitters—specifically acetylcholine, dopamine, serotonin, and noradrenaline —fall significantly. The central cholinergic deficit is the primary neurobiological substrate for perioperative cognitive vulnerability.
Minimum Alveolar Concentration (MAC): The MAC for all volatile inhalational anaesthetics decreases predictably by approximately 6% per decade beyond 40 years of age . For example, a 2.0% MAC of sevoflurane in a 40-year-old decreases to approximately 1.5% to 1.6% in an 80-year-old.
Intravenous Agent Sensitivity: Pharmacodynamic sensitivity to GABA-ergic agents (propofol, midazolam, etomidate) and opioids is markedly enhanced. Induction doses of propofol must be reduced by 30% to 50% , administered slowly to avoid unbuffered hypotension and prolonged apnea.
Postoperative Delirium (POD) vs Cognitive Dysfunction (POCD):
POD: An acute, fluctuating disturbance in attention, awareness, and cognition emerging in the immediate postoperative period (days 1 to 3). Triggered by anticholinergic drugs, pain, sleep disruption, and systemic inflammation.
POCD: A subtle, prolonged decline in cognitive performance (memory, executive function) confirmed by objective neuropsychological testing weeks to months following surgery.
- Body Composition and Distribution Volumes [ AGE-RELATED BODY COMPOSITION SHIFT ]
- |
- +----------------------------+----------------------------+
- | |
- [ Total Body Water Drops ~15% ] [ Adipose Mass Increases +20-40% ]
- [ Skeletal Muscle Mass Declines (Sarcopenia) ] [ Lipophilic Compartment Expands ]
- | |
- Smaller Vd for Water-Soluble Drugs Larger Vd for Lipid-Soluble Drugs
(Higher Initial Peak Concentrations: (Prolonged Elimination Half-life:
- e.g. Rocuronium, Digoxin) e.g. Fentanyl, Diazepam, Thiopental)
- Plasma Protein Binding
Serum Albumin: Albumin concentrations decline by 15% to 20% due to decreased hepatic synthesis. Because acidic drugs (e.g. thiopental, warfarin, phenytoin), and some others such as diazepam, bind predominantly to albumin, the free, pharmacologically active unbound fraction is increased, intensifying drug effects at standard doses.
Alpha-1 Acid Glycoprotein ( α 1 \alpha_1 α 1 -AGP): As an acute-phase reactant, α 1 \alpha_1 α 1 -AGP levels remain stable or increase with age. Binding of basic drugs (e.g. lidocaine, bupivacaine, many opioids) is preserved or increased.
Hepatic and Renal Elimination
Hepatic Clearance: Hepatic parenchyma and total liver blood flow decrease by 20% to 40% with advancing age (~10% per decade). Phase I cytochrome P450 reactions (oxidation, reduction) decline significantly, whereas Phase II conjugation reactions (glucuronidation) are relatively preserved.
Renal Clearance: Renal cortical mass declines, and functioning glomeruli are lost. Renal blood flow and GFR decrease by approximately 1 mL/min/year after age 40 .
The Sarcopenia Paradox: Because skeletal muscle mass and daily endogenous creatinine generation fall in tandem with GFR, serum creatinine often remains falsely normal (e.g. 70-90 μ mol/L \mu\text{mol/L} μ mol/L ) despite GFR declining by 50%. Relying solely on serum creatinine leads to severe overdosing of renally cleared drugs (e.g. sugammadex, low-molecular-weight heparin, aminoglycosides, morphine metabolites). Creatinine clearance must be estimated using the Cockcroft-Gault equation:
CrCl = ( 140 − age ) × weight (kg) 72 × serum Cr (mg/dL) × [ 0.85 if female ] \text{CrCl} = \frac{(140 - \text{age}) \times \text{weight (kg)}}{72 \times \text{serum Cr (mg/dL)}} \times [0.85 \text{ if female}] CrCl = 72 × serum Cr (mg/dL) ( 140 − age ) × weight (kg) × [ 0.85 if female ]
- 4. Perioperative Thermoregulation and Hypothermia
- Hypothalamic Thermal Control and Anaesthetic Disruption
The Interthreshold Range: The preoptic anterior hypothalamus regulates body temperature within a tightly controlled interthreshold range of 0.2°C to 0.4°C . Within this narrow window, no autonomic thermoregulatory defenses are active.
Anaesthetic Widening of the Range: Both general anaesthetics (volatile agents, propofol, opioids) and neuraxial blocks widen this interthreshold range roughly 20-fold (to about 2.0°C to 4.0°C) . They elevate the warm-defense (sweating) threshold while substantially depressing the cold-defense thresholds (vasoconstriction, non-shivering thermogenesis, and shivering). Consequently, the patient becomes poikilothermic, matching ambient temperature unless active warming is applied.
- The Three Phases of Hypothermia Under General Anaesthesia Core Temp (°C)
- 37.0 |----
- | \ Phase 1: Internal Thermal Redistribution
- 36.0 | \ (Core-to-peripheral heat flux via vasodilation)
- | +-------
- 35.0 | \ Phase 2: Linear Heat Loss
- | \ (Environmental loss > Metabolic production)
- 34.0 | +------------------ Phase 3: Thermal Plateau
- +----------------------------------------- (Vasoconstriction engaged)
- 0 1 2 3 4 Time (Hours)
Phase 1: Internal Thermal Redistribution (First 30 to 60 minutes):
Core temperature drops rapidly by 1.0°C to 1.5°C .
General anaesthetics cause widespread peripheral vasodilation and abolish tonic pre-capillary vasoconstriction, opening arteriovenous shunts.
Warm blood from the central core compartment (trunk, thoracic viscera, brain) flows into the cold peripheral thermal compartment (limbs), while cooler blood returns to the core.
Key Mechanism: This initial drop is an internal thermal gradient redistribution , not net heat loss to the ambient environment. Active pre-warming for 15 to 30 minutes preoperatively eliminates this core-to-periphery gradient.
Phase 2: Linear Heat Loss (Hours 1 to 3):
Core temperature declines steadily at a slower, linear rate.
Driven by environmental heat loss exceeding metabolic heat production (which is reduced by 20% to 30% under general anaesthesia due to loss of muscle tone and decreased cellular metabolism).
Phase 3: Thermal Plateau Phase (Hours 3 to 5+):
Core temperature stabilizes and ceases falling.
When core temperature drops to the anaesthetic-lowered vasoconstriction threshold (typically ~34.5°C to 35.0°C), hypothalamic vasoconstriction triggers, restoring peripheral vasoconstriction, confining metabolic heat to the core, and halting further core cooling.
Physical Mechanisms of Heat Loss in the Operating Theatre
Mechanism Contribution Physical Basis Preventive Clinical Strategy
Radiation 40% to 60% Transfer of infrared electromagnetic thermal energy from warm exposed skin to cool surrounding walls and ceilings; proportional to T patient 4 − T wall 4 T_{\text{patient}}^4 - T_{\text{wall}}^4 T patient 4 − T wall 4 . Maintain ambient OR temperature > 21 ∘ C >21^\circ\text{C} > 2 1 ∘ C ; cover exposed skin with drapes/reflective blankets.
Convection 25% to 30% Transfer of thermal energy to ambient moving air currents moving over the patient; accelerated by laminar airflow ventilation. Forced-air warming blankets; minimize air currents over patient.
Evaporation 15% to 20% Latent heat of vaporization ( 0.58 kcal/g H 2 O 0.58\text{ kcal/g } \text{H}_2\text{O} 0.58 kcal/g H 2 O ) from exposed viscera, open surgical cavities, skin prep, and unhumidified breathing circuits. Active heated humidifiers / HME filters; warm irrigation fluids; minimize visceral exposure.
Conduction < 5% Direct thermal transfer to solid surfaces in physical contact with the patient (unwarmed tables, cold gel pads, unheated IV infusions). Conductive warming mattresses; fluid warmers for all IV fluids and blood products.
Pathophysiological Complications of Inadvertent Perioperative Hypothermia ( < 36.0 ∘ C < 36.0^\circ\text{C} < 36. 0 ∘ C )
Coagulopathy and Haemorrhage: Coagulation cascade enzymatic kinetics and platelet activation/aggregation are temperature-dependent. Each 1.0°C drop in core temperature increases intraoperative blood loss by roughly 16% and elevates the relative risk of allogeneic transfusion by 22% . Importantly, standard laboratory coagulation panels (PT, aPTT) are warmed to 37.0°C in the laboratory, completely masking this in vivo hypothermic coagulopathy.
Surgical Site Infection and Impaired Wound Healing: Core hypothermia triggers thermoregulatory peripheral vasoconstriction, causing profound subcutaneous tissue hypoxia. Tissue hypoxia impairs neutrophil oxidative bacterial killing and reduces fibroblast collagen deposition, increasing surgical site infection rates 3-fold .
Prolonged Drug Duration: Hepatic biotransformation enzyme activity slows, and renal excretion declines. The duration of action of non-depolarizing neuromuscular blocking agents (e.g. rocuronium, vecuronium) is prolonged by over 100% , predisposing to postoperative residual curarization.
Adverse Cardiac Events: Hypothermia triggers sympathetic activation, elevating circulating noradrenaline levels, systemic vascular resistance, and blood pressure. The incidence of morbid cardiac events (myocardial ischemia, ventricular arrhythmias) is tripled in hypothermic elderly patients.
Post-Anaesthetic Shivering: Post-extubation shivering increases total body oxygen consumption by 100% to 400% , inducing systemic hypoxaemia, carbon dioxide retention, lactic acidosis, and dangerous spikes in intraocular and intracranial pressures. Intravenous pethidine (meperidine 12.5-25 mg) or clonidine effectively suppresses shivering via central alpha-2 and opioid receptor modulation.